Evidence map›Paper›PMID 24349219›Full record

ArticlePloS one2013

KIAA1462, a coronary artery disease associated gene, is a candidate gene for late onset Alzheimer disease in APOE carriers.

Deborah G Murdock, Yuki Bradford, Nathalie Schnetz-Boutaud, Ping Mayo, Melissa J Allen, Laura N D'Aoust, Xueying Liang, Sabrina L Mitchell, Stephan Zuchner, Gary W Small and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Functional Mutation inInternational journal of molecular sciences · 2018
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Deborah G MurdockCenter for Human Genetics Research and Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America.
Yuki BradfordCenter for Human Genetics Research and Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America.
Nathalie Schnetz-BoutaudCenter for Human Genetics Research and Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America.
Ping MayoCenter for Human Genetics Research and Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America.
Melissa J AllenCenter for Human Genetics Research and Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America.
Laura N D'AoustCenter for Human Genetics Research and Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America.
Xueying LiangCenter for Human Genetics Research and Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America.
Sabrina L MitchellCenter for Human Genetics Research and Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America.
Stephan ZuchnerMiami Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
Gary W SmallSemel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, California, United States of America.
John R GilbertMiami Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
Margaret A Pericak-VanceMiami Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
Jonathan L HainesCenter for Human Genetics Research and Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America.
Center for Human Genetics · USUniversity of Miami · USVanderbilt University · USUniversity of California, Los Angeles · US

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
YOHIMBINE AS A MODEL OF ORTHOSTATIC INTOLERANCEM01RR000095 · NCRR · VANDERBILT UNIVERSITY · PI DRAKE, WONDER P. · 1985 to 2008
$38.3M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
A Natonal Resource for Postmortem Brain ResearchR24MH068855 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI BENES, FRANCINE M. · 2003 to 2012
$14.8M
An Integrated Genomic Approach to Alzheimer DiseaseR01AG019757 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PERICAK-VANCE, MARGARET A. · 2002 to 2006
$4.8M
Alzheimer's Disease and Gene Discovery on Chromosome 9R01AG021547 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PERICAK-VANCE, MARGARET A. · 2003 to 2007
$3.1M
Revealing Epistasis in Alzheimer DiseaseR01AG020135 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MARTIN, EDEN R. · 2002 to 2006
$2.7M
NCRR NIH HHS M01 RR000095NCRR NIH HHS M01 RR-00095NIA NIH HHS AG019757NIA NIH HHS AG021547NIA NIH HHS AG20135NIA NIH HHS AG21886NIA NIH HHS R01 AG019757NIA NIH HHS R01 AG020135NIA NIH HHS R01 AG021547NIA NIH HHS U24 AG021886NIGMS NIH HHS T32 GM007347NIMH NIH HHS R24 MH068855NIMH NIH HHS R24MH068855
6 · The paper itself

Abstract

Alzheimer disease (AD) is a devastating neurodegenerative disease affecting more than five million Americans. In this study, we have used updated genetic linkage data from chromosome 10 in combination with expression data from serial analysis of gene expression to choose a new set of thirteen candidate genes for genetic analysis in late onset Alzheimer disease (LOAD). Results in this study identify the KIAA1462 locus as a candidate locus for LOAD in APOE4 carriers. Two genes exist at this locus, KIAA1462, a gene associated with coronary artery disease, and "rokimi", encoding an untranslated spliced RNA The genetic architecture at this locus suggests that the gene product important in this association is either "rokimi", or a different isoform of KIAA1462 than the isoform that is important in cardiovascular disease. Expression data suggests that isoform f of KIAA1462 is a more attractive candidate for association with LOAD in APOE4 carriers than "rokimi" which had no detectable expression in brain.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAllelesAlzheimer DiseaseApolipoprotein E4BrainCell Adhesion MoleculesChromosomes, Human, Pair 10Coronary Artery DiseaseDatabases, GeneticExonsFemaleGene Expression RegulationGenetic LociGenome, HumanHeterozygoteApolipoprotein E4Cell Adhesion MoleculesJCAD protein, humanRNA

Identifiers

PMID24349219
PMCPMC3861372
OpenAlexW2066406899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.